Current stage-Stage IV Page 2 Posts on Medivizor
Navigation Menu

Current stage-Stage IV Posts on Medivizor

Surgery to remove the main tumor in patients with breast cancer that has spread

Posted by on Oct 18, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if removing the main tumor in women with cancer that has spread to other organs leads to greater survival than not removing the main tumor. The study found that the patients who had the surgery survived 47% longer than patients without the surgery. Some background Breast cancer can sometimes be caught quite...

Read More

What is the best treatment for patients with colorectal cancer and peritoneal metastasis?

Posted by on Sep 29, 2018 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) with other treatment options in patients with colorectal cancer (CRC) and peritoneal metastasis (PM; when cancer spreads to the abdominal lining). Researchers suggested that CRS + HIPEC brings the greatest...

Read More

The effect of FDG-PET imaging on patients with melanoma treated with immunotherapy.

Posted by on Sep 28, 2018 in Melanoma | 0 comments

In a nutshell The study looked at the use of FDG-PET imaging to assess long-term outcomes of treatment in patients with melanoma. Researchers found that FDG-PET imaging may be useful in predicting long-term outcomes of treatment in these patients. Some background Treatment for melanoma has vastly improved in recent years. Immunotherapies have improved...

Read More

SD-101 and pembrolizumab treatment in advanced melanoma

Posted by on Sep 15, 2018 in Melanoma | 0 comments

In a nutshell This study analysed a new medication to treat advanced melanoma called SD-101. The study found that patients responded very well to injection of the medication directly into the tumor alongside a common medication called pembrolizumab (Keytruda), although this worked best in patients who had never been treated with pembrolizumab...

Read More

Using cancer killing viruses as treatment for melanoma

Posted by on Sep 6, 2018 in Melanoma | 0 comments

In a nutshell This study wanted to analyse the current literature on using cancer killing viruses as a treatment for melanoma. The study found that there is only one virus that has been approved for use in treatment of melanoma, however there are others being developed, and current results are promising. Some background A new approach to treating...

Read More

Comparing the effectiveness of different immunotherapy drugs for patients with NSCLC

Posted by on Aug 21, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at three different immune checkpoint inhibitors and how effective they were at treating patients with non-small-cell lung cancers (NSCLC) with different levels of PD-L1 protein. The authors found that all three drugs analyzed were more effective than chemotherapy for these patients. Some background Many tumor cells have...

Read More

Comparing targeted therapy to chemotherapy for patients with advanced NSCLC

Posted by on Aug 8, 2018 in Lung cancer | 0 comments

In a nutshell This trial compared the effectiveness of alectinib (Alecensa) against chemotherapy for treating patients with ALK-positive non-small-cell lung cancer that have progressed passed previous targeted therapy. The authors determined that alectinib was more effective than chemotherapy at treating this subgroup of patients. Some background Lung...

Read More

Fulvestrant compared to aromatase inhibitors in post-menopausal women with HR+ advanced breast cancer

Posted by on Jul 16, 2018 in Breast cancer | 0 comments

In a nutshell This study aimed to look at the safety and effectiveness of fulvestrant (Faslodex) compared to aromatase inhibitors in post-menopausal women with hormone receptor-positive (HR+) breast cancer. The authors found that fulvestrant was a safe and effective treatment in these patients when compared to aromatase inhibitors. Some...

Read More

Combining therapies to treat advanced NSCLC

Posted by on Jul 14, 2018 in Lung cancer | 0 comments

In a nutshell This trial examined the effectiveness of combining the targeted therapy drug pembrolizumab (Keytruda) with chemotherapy at treating certain types of advanced non-small-cell lung cancer. The trial concluded that this combination is more beneficial than chemotherapy alone for treating this subset of patients. Some background PD-1...

Read More